Of special interest is the deletion in 9p, with a biallelic deletion in CDKN2A, well-characterized progression events in the evolution of BCP-ALL3,27 (Fig. 3c and Supplementary Fig. 12). The gene discussed is CDKN2A; the disease is leukemia, acute lymphoblastic, susceptibility to, 3.